Actively Recruiting
Using Optical Genome Mapping with Whole Genome Sequencing to Improve Diagnosis in Children with Unexplained Neurodevelopmental Disorders
Led by IRCCS Eugenio Medea · Updated on 2025-02-28
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Over half of children with neurological and neurodevelopmental disorders do not receive a clear molecular diagnosis after standard genetic testing like DNA sequencing and molecular karyotyping. This gap is due to technical limits and challenges in interpreting genetic variants and linking them to symptoms. Researchers are studying advanced sequencing technologies to provide a more complete view of genetic changes, aiming to personalize care for affected children. The project focuses on using Optical Genome Mapping OGM alongside Next-Generation Sequencing NGS to improve diagnosis in 60 children with severe disorders who previously tested negative in standard tests. The study uses OGM together with Whole Genome Sequencing WGS to detect structural genetic variants that might have been missed before. When OGM identifies possible causal variants, WGS will help locate exact breakpoints and examine genes nearby that could be affected. Additionally, transcriptome analysis will be performed on patient cells to explore how these variants impact gene activity and identify unusual gene expression or splicing changes, especially in patients with uncommon clinical features. Participants will provide samples for these advanced genetic tests once at recruitment. The main outcome measured is the correlation between genetic findings and clinical symptoms at this time. This research aims for a more comprehensive understanding of each childs condition by combining multiple genetic approaches. The study is sponsored by IRCCS Eugenio Medea and plans to complete in December 2026.
CONDITIONS
Brief Title
Expanding NGS Data with Optical Genome Mapping (OGM)
Research Team
M
Maria Clara Bonaglia PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here